208 related articles for article (PubMed ID: 38534360)
21. Low-density lipoprotein receptor deficiency reduced bone mass in mice via the c-fos/NFATc1 pathway.
Qi Q; Chen L; Sun H; Zhang N; Zhou J; Zhang Y; Zhang X; Li L; Li D; Wang L
Life Sci; 2022 Dec; 310():121073. PubMed ID: 36244411
[TBL] [Abstract][Full Text] [Related]
22. A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling.
Kang HK; Park CY; Jung SY; Jo SB; Min BM
Tissue Eng Regen Med; 2022 Dec; 19(6):1359-1376. PubMed ID: 36207661
[TBL] [Abstract][Full Text] [Related]
23. Injectable Platelet-Rich Fibrin - A Revolution in Periodontal Regeneration.
Gollapudi M; Bajaj P; Oza RR
Cureus; 2022 Aug; 14(8):e28647. PubMed ID: 36196318
[TBL] [Abstract][Full Text] [Related]
24. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
Zhu G; Chen W; Tang CY; McVicar A; Edwards D; Wang J; McConnell M; Yang S; Li Y; Chang Z; Li YP
Int J Biol Sci; 2022; 18(14):5522-5538. PubMed ID: 36147479
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-mediated immunomodulation of osteoclastogenesis.
Zhou P; Zheng T; Zhao B
Bone; 2022 Nov; 164():116540. PubMed ID: 36031187
[TBL] [Abstract][Full Text] [Related]
26. Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.
Huang J; An Q; Zhang CL; He L; Wang L
Exp Ther Med; 2022 Sep; 24(3):595. PubMed ID: 35949327
[TBL] [Abstract][Full Text] [Related]
27. A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer.
Chen ML; Yuan TT; Chuang CF; Huang YT; Chung IC; Huang WC
Mol Cancer Ther; 2022 Aug; 21(8):1337-1347. PubMed ID: 35700013
[TBL] [Abstract][Full Text] [Related]
28. A vitronectin-derived dimeric peptide suppresses osteoclastogenesis by binding to c-Fms and inhibiting M-CSF signaling.
Jung SY; Min BM
Exp Cell Res; 2022 Sep; 418(1):113252. PubMed ID: 35697077
[TBL] [Abstract][Full Text] [Related]
29. PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
Badran M; Gozal D
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628326
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
Alfano D; Franco P; Stoppelli MP
Front Cell Dev Biol; 2022; 10():818616. PubMed ID: 35493073
[TBL] [Abstract][Full Text] [Related]
31. Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.
Calvier L; Herz J; Hansmann G
JACC Basic Transl Sci; 2022 Feb; 7(2):164-180. PubMed ID: 35257044
[TBL] [Abstract][Full Text] [Related]
32. Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives.
Terkawi MA; Matsumae G; Shimizu T; Takahashi D; Kadoya K; Iwasaki N
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163708
[TBL] [Abstract][Full Text] [Related]
33. The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Ismail AA; Shaker BT; Bajou K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008762
[TBL] [Abstract][Full Text] [Related]
34. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
Rasmussen LJH; Petersen JEV; Eugen-Olsen J
Front Immunol; 2021; 12():780641. PubMed ID: 34925360
[TBL] [Abstract][Full Text] [Related]
35. Alpha2-antiplasmin deficiency affects depression and anxiety-like behavior and apoptosis induced by stress in mice.
Kanno Y; Tsuchida K; Maruyama C; Hori K; Teramura H; Asahi S; Matsuo O; Ozaki KI
J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):633-638. PubMed ID: 34913624
[TBL] [Abstract][Full Text] [Related]
36. α2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy.
Kanno Y; Hirota M; Matsuo O; Ozaki KI
Mol Biol Rep; 2022 Jan; 49(1):205-215. PubMed ID: 34709571
[TBL] [Abstract][Full Text] [Related]
37. Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.
Xue L; Tao L; Li X; Wang Y; Wang B; Zhang Y; Gao N; Dong Y; Xu N; Xiong C; Zhou T; Liu Z; Liu H; He J; Li K; Geng Y; Li M
Sci Rep; 2021 Aug; 11(1):16903. PubMed ID: 34413382
[TBL] [Abstract][Full Text] [Related]
38. Plasmin, Immunity, and Surgical Site Infection.
Hastings S; Myles PS; Medcalf RL
J Clin Med; 2021 May; 10(10):. PubMed ID: 34065949
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice.
Kanno Y; Shu E; Niwa H; Seishima M; Ozaki KI
Mol Biol Rep; 2021 Apr; 48(4):3431-3437. PubMed ID: 33913094
[TBL] [Abstract][Full Text] [Related]
40. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
